Completed OBSERVATIONAL NCT05366621

Post-fracture Medication and Mortality

The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures

Sponsor: National Cheng-Kung University Hospital

Conditions Adherence, Medication Drug Therapy Mortality Osteoporosis Osteoporosis Fracture

Interventions Anti-osteoporosis medications

Updated 6 times since 2022 Last updated: Mar 31, 2023 Started: Nov 1, 2020 Primary completion: Sep 30, 2021 Completion: Oct 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05366621, this observational or N/A phase trial focuses on Adherence, Medication and Drug Therapy and remains completed. Sponsored by National Cheng-Kung University Hospital, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Dec 2025 — Present [monthly]

Completed
Sep 2025 — Dec 2025 [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2023 — Jul 2024 [monthly]

Completed

▶ Show 1 earlier version

Jun 2022 — May 2023 [monthly]

Completed

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cheng-Kung University Hospital

Data source: National Cheng-Kung University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tainan, Taiwan